Hikmet Al‐Hiti - Concepedia

Author

Hikmet Al‐Hiti

Institute of Clinical and Experimental Medicine

Also Known As

H ALHITI, H Al-Hiti, H. AL-HITI, H. Al-Hiti, Hikmet Al-Hiti, Hikmet Al‐Hiti, Jana Binova, PAVLÍKOVÁ, Petra, Petra Pavlíková

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Institute of Clinical and Experimental Medicine Charles University University Hospital Brno Na Homolce Hospital Actelion (Switzerland)

About

Hikmet Al‐Hiti is an author at Institute of Clinical and Experimental Medicine specializing in medicine, cardiovascular disease, and pulmonary vascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	8	1.4K
2	Public Health	5	6	1.4K
3	Pharmacology	2	3	373
4	Cardiothoracic Surgery	1	1	11
5	Emergency Medicine	1	1	11

Hikmet Al‐Hiti

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial Nazzareno Galiè, LJ Rubin, Pavel Jansa, The Lancet HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseAntihypertensive TherapyEarly Study	2008	913
Macitentan in pulmonary hypertension due to left ventricular dysfunction Jean‐Luc Vachiéry, Marion Delcroix, Hikmet Al‐Hiti, European Respiratory Journal	2018	193
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza, The Lancet Respiratory Medicine HypertensionPulmonary Arterial HypertensionPhosphodiesterase-5 InhibitorsCardiovascular DiseaseMedicine	2021	151
Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry Pavel Jansa, Jiří Jarkovský, Hikmet Al‐Hiti, BMC Pulmonary Medicine	2014	74
Transpulmonary B-Type Natriuretic Peptide Uptake and Cyclic Guanosine Monophosphate Release in Heart Failure and Pulmonary Hypertension Vojtěch Melenovský, Hikmet Al‐Hiti, Ludmila Kazdová, Journal of the American College of Cardiology HypertensionHeart FailurePulmonary Arterial HypertensionPulmonary CirculationCardiovascular Disease	2009	71
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients Gérald Simonneau, Nazzareno Galiè, Pavel Jansa, International Journal of Cardiology	2014	57
The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: A case–control study Adrian Reichenbach, Hikmet Al‐Hiti, Ivan Málek, International Journal of Cardiology HypertensionHeart FailurePulmonary Arterial HypertensionPulmonary CirculationCardiovascular Disease	2012	37
Proof-Of-Concept Study To Investigate The Efficacy, Hemodynamics And Tolerability Of Terguride Vs. Placebo In Subjects With Pulmonary Arterial Hypertension: Results Of A Double Blind, Randomised, Prospective Phase IIa Study Hossein Ardeschir Ghofrani, Hikmet Al‐Hiti, Anton Vonk Noordegraaf, HypertensionPulmonary Arterial HypertensionVenous ThrombosisCardiovascular DiseaseAntihypertensive Therapy	2012	34
Positive Influence of Being Overweight/Obese on Long Term Survival in Patients Hospitalised Due to Acute Heart Failure Simona Littnerová, Jiří Pařenica, Jindřich Špinar, PLoS ONE	2015	21
Acute Unloading Effects of Sildenafil Enhance Right Ventricular–Pulmonary Artery Coupling in Heart Failure Luca Monzo, Adrian Reichenbach, Hikmet Al‐Hiti, Journal of Cardiac Failure Heart FailurePulmonary CirculationCardiovascular DiseaseCardiovascular PharmacologyAcute Unloading Effects	2020	20

Page 1